Stock Analiz

AMGN vs RVMD stock comparison

Amgen vs. Revolution Medicines · data as of November 13, 2026

Amgen (AMGN) has a market value of about $251.9B, Revolution Medicines (RVMD) about $37.3B. Over their latest twelve months Amgen had revenue of $38.9B and Revolution Medicines $198M.

On our five checks Amgen scores higher: 2.4 out of 5 (weak) against 0.6 (weak).

By area, the stronger company is Amgen on future growth; Amgen on track record; Amgen on shareholder returns.

Amgen leads on 12 of the compared lines and Revolution Medicines on 1.

Side by side

AMGNRVMD
Size and price
Market cap$251.9B$37.3B
Share price$465.67$172.29
Score
Overall score (of 5)2.40.6
Value00
Future growth31
Track record30
Financial health22
Shareholder returns40
Valuation
P/E (TTM)27.0—
Forward P/E19.5—
Price / free cash flow26.3—
Price / sales6.5188.6
EV / EBITDA17.1—
PEG9.18—
DCF value vs. price−26%—
Business
Revenue$38.9B$198M
Net income$9.4B-$1.9B
Free cash flow$9.6B-$1.4B
Net margin24.1%-946.8%
Gross margin (5-yr avg.)69.9%—
ROIC (5-yr avg.)13.5%-36.5%
Growth
Revenue growth (1 yr)10.0%—
Revenue growth (5 yrs, per year)7.6%-100.0%
EPS growth (5 yrs, per year)2.9%—
Balance sheet and payouts
Net cash (cash minus debt)-$40.8B—
Dividend yield2.16%None
Shareholder yield2.2%0.0%
Analysts
Upside to average target−7%+59%
Consensus ratingHoldStrong buy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: AMGN TTM to September 30, 2026, RVMD TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Amgen or Revolution Medicines?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Amgen scores 2.4 out of 5 and Revolution Medicines 0.6; the table shows where each one is stronger.

Which grows faster, Amgen or Revolution Medicines?

Over five years Amgen grew revenue about 7.6% a year and Revolution Medicines about -100.0% a year.

Which pays a higher dividend?

Amgen yields 2.16% and Revolution Medicines nothing (no dividend).

Full Amgen analysis → Full Revolution Medicines analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.